Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Seneschal

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Skin Health and Disease|August 4, 2023
Prevalence of excessive daytime sleepiness among patients with atopic dermatitisBruno Halioua, Jonathan Taieb, Julien Seneschal, et al.
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.
Nature Reviews. Disease Primers|December 4, 2025
VitiligoJulien Seneschal, Jung Min Bae, Khaled Ezzedine, et al.
Acta Dermato-Venereologica|February 21, 2017
Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha InhibitorsAnne-Sophie Darrigade, Brigitte Milpied, Marie-Elise Truchetet, et al.
Acta Dermato-Venereologica|March 29, 2023
Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot StudyAurore Dupont, Alexia Eyraud, Brigitte Milpied, et al.
Acta Dermato-Venereologica|February 18, 2025
The Impact of Atopic Dermatitis on Employment and Productivity: A French StudyKhaled Ezzedine, Julien Seneschal, Florence Corgibet, et al.
Frontiers in Immunology|November 29, 2023
Inhibition of T-cell activity in alopecia areata: recent developments and new directionsThierry Passeron, Brett King, Julien Seneschal, et al.
JAAD International|October 29, 2021
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional studyLéa Dousset, Alize Pacaud, Thomas Barnetche, et al.
Archives of Dermatology|April 18, 2012
Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation patternKhaled Ezzedine, Abou Diallo, Christine Léauté-Labrèze, et al.
The World Allergy Organization Journal|August 19, 2024
Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumabRémi Strizzolo, Julien Seneschal, Angèle Soria, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Skin Health and Disease|August 4, 2023
Prevalence of excessive daytime sleepiness among patients with atopic dermatitisBruno Halioua, Jonathan Taieb, Julien Seneschal, et al.
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.
Nature Reviews. Disease Primers|December 4, 2025
VitiligoJulien Seneschal, Jung Min Bae, Khaled Ezzedine, et al.
Acta Dermato-Venereologica|February 21, 2017
Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha InhibitorsAnne-Sophie Darrigade, Brigitte Milpied, Marie-Elise Truchetet, et al.
Acta Dermato-Venereologica|March 29, 2023
Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot StudyAurore Dupont, Alexia Eyraud, Brigitte Milpied, et al.
Acta Dermato-Venereologica|February 18, 2025
The Impact of Atopic Dermatitis on Employment and Productivity: A French StudyKhaled Ezzedine, Julien Seneschal, Florence Corgibet, et al.
Frontiers in Immunology|November 29, 2023
Inhibition of T-cell activity in alopecia areata: recent developments and new directionsThierry Passeron, Brett King, Julien Seneschal, et al.
JAAD International|October 29, 2021
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional studyLéa Dousset, Alize Pacaud, Thomas Barnetche, et al.
Archives of Dermatology|April 18, 2012
Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation patternKhaled Ezzedine, Abou Diallo, Christine Léauté-Labrèze, et al.
The World Allergy Organization Journal|August 19, 2024
Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumabRémi Strizzolo, Julien Seneschal, Angèle Soria, et al.
Pageof 19